Product Name
forkhead box E3 (FOXE3), ELISA Kit
Full Product Name
Mouse Forkhead box protein E3, FOXE3 ELISA Kit
Product Synonym Names
Mouse Forkhead box protein E3 (FOXE3) ELISA kit; FKHL12; FREAC8; forkhead; drosophila; homolog-like 12; forkhead box E3
Product Gene Name
FOXE3 elisa kit
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Request for Current Manual Insert
Request Current Manual
3D Structure
ModBase 3D Structure for Q9QY14
Preparation and Storage
Store all reagents at 2-8 degree C
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual.
Other Notes
Small volumes of FOXE3 elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for FOXE3 purchase
MBS9331382 is a ready-to-use microwell, strip plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the forkhead box E3 (FOXE3) ELISA Kit target analytes in
biological samples. The concentration gradients of the kit standards or positive controls render a theoretical kit detection range in biological research samples containing FOXE3. The ELISA analytical biochemical technique of the MBS9331382 kit is based on FOXE3 antibody-FOXE3 antigen interactions (immunosorbency) and an HRP colorimetric detection system to detect FOXE3 antigen targets in samples. The ELISA Kit is designed to detect native, not recombinant, FOXE3. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, secretions. Quality control assays assessing reproducibility identified the intra-assay CV (%) and inter-assay CV(%).
NCBI/Uniprot data below describe general gene information for FOXE3. It may not necessarily be applicable to this product.
NCBI Accession #
NP_056573.1
[Other Products]
NCBI GenBank Nucleotide #
NM_015758.2
[Other Products]
UniProt Primary Accession #
Q9QY14
[Other Products]
UniProt Related Accession #
Q9QY14[Other Products]
Molecular Weight
30,541 Da
NCBI Official Full Name
forkhead box protein E3
NCBI Official Synonym Full Names
forkhead box E3
NCBI Official Symbol
Foxe3??[Similar Products]
NCBI Official Synonym Symbols
dyl; rct; FREAC8
??[Similar Products]
NCBI Protein Information
forkhead box protein E3; dysgenetic lens; Rinshoken cataract
UniProt Protein Name
Forkhead box protein E3
Protein Family
Forkhead box protein
UniProt Gene Name
Foxe3??[Similar Products]
UniProt Entry Name
FOXE3_MOUSE
UniProt Comments for FOXE3
FOXE3: Defects in FOXE3 are a cause of anterior segment mesenchymal dysgenesis (ASMD); also known as anterior segment ocular dysgenesis (ASOD). ASMD consists of a range of developmental defects in structures at the front of the eye, resulting from abnormal migration or differentiation of the neural crest derived mesenchymal cells that give rise to the cornea, iris, and other components of the anterior chamber during eye development. Mature anterior segment anomalies are associated with an increased risk of glaucoma and corneal opacity. Conditions falling within the phenotypic spectrum include aniridia, posterior embryotoxon, Axenfeld anomaly, Reiger anomaly/syndrome, Peters anomaly, and iridogoniodysgenesis. Defects in FOXE3 are a cause of congenital primary aphakia (CPA). Aphakia is a rare congenital eye disorder in which the lens is missing. It has been histologically subdivided into primary and secondary forms, in accordance with the severity of defects of the ocular tissues, whose development requires the initial presence of a lens. CPA results from an early developmental arrest, around the 4th-5th week of gestation in humans, that prevents the formation of any lens structure and leads to severe secondary ocular defects, including a complete aplasia of the anterior segment of the eye. In contrast, in secondary aphakic eyes, lens induction has occurred, and the lens vesicle has developed to some degree but finally has progressively resorbed perinatally, leading, therefore, to less-severe ocular defects.
Protein type: DNA-binding
Cellular Component: transcription factor complex; nucleus
Molecular Function: DNA binding; sequence-specific DNA binding; transcription factor activity
Biological Process: transcription from RNA polymerase II promoter; regulation of transcription from RNA polymerase II promoter; camera-type eye development; transcription, DNA-dependent; eye development; regulation of transcription, DNA-dependent; cell development; positive regulation of epithelial cell proliferation
Research Articles on FOXE3
1. The observed changes in the expression of FoxE3 suggest that Msx2 is an important contributor in controlling transcription of target genes critical for early eye development.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.